IBDEI1KY ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,28393,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28393,1,2,0)
 ;;=2^97039
 ;;^UTILITY(U,$J,358.3,28393,1,3,0)
 ;;=3^Unlisted PT Modality
 ;;^UTILITY(U,$J,358.3,28394,0)
 ;;=97124^^175^1805^10^^^^1
 ;;^UTILITY(U,$J,358.3,28394,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28394,1,2,0)
 ;;=2^97124
 ;;^UTILITY(U,$J,358.3,28394,1,3,0)
 ;;=3^Therapeutic Massage
 ;;^UTILITY(U,$J,358.3,28395,0)
 ;;=97110^^175^1805^9^^^^1
 ;;^UTILITY(U,$J,358.3,28395,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28395,1,2,0)
 ;;=2^97110
 ;;^UTILITY(U,$J,358.3,28395,1,3,0)
 ;;=3^Therapeutic Ex/Record/Flex
 ;;^UTILITY(U,$J,358.3,28396,0)
 ;;=97035^^175^1805^11^^^^1
 ;;^UTILITY(U,$J,358.3,28396,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28396,1,2,0)
 ;;=2^97035
 ;;^UTILITY(U,$J,358.3,28396,1,3,0)
 ;;=3^Ultrasound Ea 15Min
 ;;^UTILITY(U,$J,358.3,28397,0)
 ;;=20552^^175^1806^6^^^^1
 ;;^UTILITY(U,$J,358.3,28397,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28397,1,2,0)
 ;;=2^20552
 ;;^UTILITY(U,$J,358.3,28397,1,3,0)
 ;;=3^Trigger Point Inj,1-2 Muscles
 ;;^UTILITY(U,$J,358.3,28398,0)
 ;;=20553^^175^1806^7^^^^1
 ;;^UTILITY(U,$J,358.3,28398,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28398,1,2,0)
 ;;=2^20553
 ;;^UTILITY(U,$J,358.3,28398,1,3,0)
 ;;=3^Trigger Point Inj,3 or More Muscles
 ;;^UTILITY(U,$J,358.3,28399,0)
 ;;=64405^^175^1806^5^^^^1
 ;;^UTILITY(U,$J,358.3,28399,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28399,1,2,0)
 ;;=2^64405
 ;;^UTILITY(U,$J,358.3,28399,1,3,0)
 ;;=3^Nerve Block,Occipital
 ;;^UTILITY(U,$J,358.3,28400,0)
 ;;=64615^^175^1806^4^^^^1
 ;;^UTILITY(U,$J,358.3,28400,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28400,1,2,0)
 ;;=2^64615
 ;;^UTILITY(U,$J,358.3,28400,1,3,0)
 ;;=3^Chemodenervation Muscle for Migraine
 ;;^UTILITY(U,$J,358.3,28401,0)
 ;;=J0585^^175^1806^2^^^^1
 ;;^UTILITY(U,$J,358.3,28401,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28401,1,2,0)
 ;;=2^J0585
 ;;^UTILITY(U,$J,358.3,28401,1,3,0)
 ;;=3^Botulinum Toxin A,per unit
 ;;^UTILITY(U,$J,358.3,28402,0)
 ;;=J0587^^175^1806^3^^^^1
 ;;^UTILITY(U,$J,358.3,28402,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28402,1,2,0)
 ;;=2^J0587
 ;;^UTILITY(U,$J,358.3,28402,1,3,0)
 ;;=3^Botulinum Toxin B,100 units
 ;;^UTILITY(U,$J,358.3,28403,0)
 ;;=J0586^^175^1806^1^^^^1
 ;;^UTILITY(U,$J,358.3,28403,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28403,1,2,0)
 ;;=2^J0586
 ;;^UTILITY(U,$J,358.3,28403,1,3,0)
 ;;=3^Botulinum Toxin A,5 units
 ;;^UTILITY(U,$J,358.3,28404,0)
 ;;=441.4^^176^1807^1
 ;;^UTILITY(U,$J,358.3,28404,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28404,1,2,0)
 ;;=2^441.4
 ;;^UTILITY(U,$J,358.3,28404,1,5,0)
 ;;=5^ABDOM AORTIC ANEURYSM W/O RUP
 ;;^UTILITY(U,$J,358.3,28404,2)
 ;;=^269769
 ;;^UTILITY(U,$J,358.3,28405,0)
 ;;=303.90^^176^1807^2
 ;;^UTILITY(U,$J,358.3,28405,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28405,1,2,0)
 ;;=2^303.90
 ;;^UTILITY(U,$J,358.3,28405,1,5,0)
 ;;=5^ALCOHOL DEPENDENCE NEC/NOS
 ;;^UTILITY(U,$J,358.3,28405,2)
 ;;=^268187
 ;;^UTILITY(U,$J,358.3,28406,0)
 ;;=995.3^^176^1807^3
 ;;^UTILITY(U,$J,358.3,28406,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28406,1,2,0)
 ;;=2^995.3
 ;;^UTILITY(U,$J,358.3,28406,1,5,0)
 ;;=5^ALLERGIC REACTION
 ;;^UTILITY(U,$J,358.3,28406,2)
 ;;=^60275
 ;;^UTILITY(U,$J,358.3,28407,0)
 ;;=477.9^^176^1807^4
 ;;^UTILITY(U,$J,358.3,28407,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28407,1,2,0)
 ;;=2^477.9
 ;;^UTILITY(U,$J,358.3,28407,1,5,0)
 ;;=5^ALLERGIC RHINITIS NOS
 ;;^UTILITY(U,$J,358.3,28407,2)
 ;;=^4955
 ;;^UTILITY(U,$J,358.3,28408,0)
 ;;=331.0^^176^1807^5
 ;;^UTILITY(U,$J,358.3,28408,1,0)
 ;;=^358.31IA^5^2
